Sarah Pringle
The San Francisco PE shop's investment in the physical therapy provider dates to June 2016.
The Seattle firm's life sciences vehicle invests in company creation, early-stage venture, late private and public opportunities.
Pamplona formed nThrive in 2015 when it married MedAsset's revenue cycle management business with existing platform Precyse.
The anticipated auction follows the Chicago buyout shop’s majority exit of Advarra, which commanded a $1.3 bln valuation.
Harris Williams and Houlihan Lokey scored the sell-side adviser mandate, with a process poised to launch imminently.
Congressional inquiries facing APP's larger PE-backed peers, TeamHealth and EmCare, ultimately weighed on the process.
The deal for the IDD-focused pharmacy concludes a GuideCap Partners-run sales process.
The healthcare-focused firm, launched in 2019 by a former Sterling Partners investor and former AlixPartners consultant, is investing on a deal-by-deal basis.
The Goldman-run auction for the opioid addiction treatment company was hoping to fetch a $1 billion-plus pricetag.
Premier's hospital owners evaluate whether to roll equity or cash out in a potential sale.